biotech
biotech Articles
Mustang Bio shares more than doubled on Thursday after the company announced a breakthrough that cured eight infants dealing with the "Bubble Boy" immune disorder.
Published:
Last Updated:
CRISPR Therapeutics shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track Designation for its treatment for transfusion-dependent beta thalassemia.
Published:
Last Updated:
Clovis Oncology may have thought that it could sneak an announcement by late on Friday, but its shares were definitely paying the price Monday morning.
Published:
Last Updated:
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment of seizures associated with Dravet syndrome.
Published:
Last Updated:
PhaseBio shares made a sizeble gain on Tuesday morning after the FDA provided a critical update for the firm.
Published:
Last Updated:
Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA interference therapeutics for a broad range of diseases.
Published:
Last Updated:
Coherus BioSciences shares jumped on Monday morning after the firm released updated sales for its first quarter.
Published:
Last Updated:
Merrimack Pharmaceuticals shares dipped on Friday after the firm announced that it would be discontinuing one of its cancer drugs as well as conducting layoffs.
Published:
Last Updated:
Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment.
Published:
Last Updated:
Aptinyx has announced positive preclinical data on its drug candidate demonstrating reversal of cognitive deficits in a nonhuman primate model of Parkinson’s disease.
Published:
Last Updated:
Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.
Published:
Last Updated:
Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with Pfizer.
Published:
Last Updated:
Apyx Medical shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket notification 510(k) regulatory clearance of...
Published:
Last Updated:
Tricida shares jumped on Thursday after the firm announced results from its chronic kidney disease study.
Published:
Last Updated: